Phage display as a tool for protease ligand discovery
Related Experiment Video
Updated: Oct 2, 2026

06:30
Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases
Published on: August 27, 2021
1Dyax Corp, Cambridge, MA 02139, USA. anixon@dyax.com
Current Pharmaceutical Biotechnology
|March 9, 2002
Abstract:
Proteolytic enzymes have been implicated as the pathological agent in a number of disease states. For this reason proteases are attractive therapeutic targets. Phage display of peptide libraries can be used to identify peptides that may be used either directly as inhibitors or serve as leads in the generation of prodrugs and peptidomimetics.

